Key result
MyD88 deficiency protected mice from experimental autoimmune myocarditis by impairing the capacity of dendritic cells to prime heart-specific CD4+ T cells.
Why the study?
Does MyD88 signaling control the induction of autoimmune myocarditis in a mouse model?
Does MyD88 signaling control the induction of autoimmune myocarditis in a mouse model?
MyD88 signaling in self-antigen presenting dendritic cells is critical for the induction of autoimmune myocarditis, suggesting MyD88 as a potential therapeutic target for preventing heart-specific autoimmunity.
No takes yet. Share an insight, caveat, or question.
MyD88 may represent a therapeutic target in autoimmune myocarditis; murine data leave open human translation.
Marty et al. (2006) studied Experimental autoimmune myocarditis. MyD88 deficiency (MyD88 -/-) vs. Control littermates (MyD88 +/+) was evaluated on Myocarditis induction. MyD88 deficiency protected mice from experimental autoimmune myocarditis by impairing the capacity of dendritic cells to prime heart-specific CD4+ T cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: